This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
Bavencio 200 mg/10 ml, concentrate for solution for infusion
INN: X
Data updated: 2026-04-11
Available in:
🇨🇿🇩🇪🇬🇧🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Merck (Schweiz) AG (CH)
ATC Code
L01FF04
Source
SWISSMEDIC
(
ARTG
)
BAVENCIO is indicated for the treatment of adults and paediatric patients 12 years and older
with metastatic Merkel cell carcinoma (mMCC). This indication is approved based on tumour
response rate, duration of response in a single arm study.,BAVENCIO is indicated for the first-line maintenance treatment of patients with locally
advanced or metastatic urothelial carcinoma (UC) whose disease has not progressed with
first-line platinum-based induction chemotherapy.,BAVENCIO in combination with axitinib is indicated for the first-line treatment of patients with advanced renal cell carcinoma (RCC).
